170 related articles for article (PubMed ID: 37358786)
1. A Case of Hypercalcemia from PTHrP-Producing Fibromyxoid Sarcoma Responsive to Glucocorticoid Therapy.
Niu I; Hsiao EC; Wustrack R; Wysolmerski JJ; Dann P; Masharani U
Calcif Tissue Int; 2023 Aug; 113(2):246-253. PubMed ID: 37358786
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone-related protein: an unusual mechanism for hypercalcemia in sarcoidosis.
Krikorian A; Shah S; Wasman J
Endocr Pract; 2011; 17(4):e84-6. PubMed ID: 21550945
[TBL] [Abstract][Full Text] [Related]
3. Effects of glucocorticoids and calcitonin on parathyroid hormone-related protein (PTHrP) gene expression and PTHrP release in human cancer cells causing humoral hypercalcemia.
Kasono K; Isozaki O; Sato K; Sato Y; Shizume K; Ohsumi K; Demura H
Jpn J Cancer Res; 1991 Sep; 82(9):1008-14. PubMed ID: 1938595
[TBL] [Abstract][Full Text] [Related]
4. Treatment of malignancy-associated hypercalcemia and cachexia with humanized anti-parathyroid hormone-related protein antibody.
Sato K; Onuma E; Yocum RC; Ogata E
Semin Oncol; 2003 Oct; 30(5 Suppl 16):167-73. PubMed ID: 14613038
[TBL] [Abstract][Full Text] [Related]
5. Cinacalcet increases renal calcium excretion in PTHrP-mediated hypercalcemia: a case report.
Faiq S; Lavelle K; Hu T; Shoback D; Ku G
BMC Endocr Disord; 2023 Jun; 23(1):133. PubMed ID: 37328745
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid-hormone-related protein-mediated hypercalcemia in benign congenital mesoblastic nephroma.
Srivastava T; Kats A; Martin TJ; Pompolo S; Alon US
Pediatr Nephrol; 2011 May; 26(5):799-803. PubMed ID: 21161280
[TBL] [Abstract][Full Text] [Related]
7. PTHrP-Induced Refractory Malignant Hypercalcemia in a Patient With Chronic Lymphocytic Leukemia Responding to Denosumab.
Salahudeen AA; Gupta A; Jones JC; Cowan RW; Vusirikala M; Kwong C; Naina HV
Clin Lymphoma Myeloma Leuk; 2015 Sep; 15(9):e137-40. PubMed ID: 26187654
[No Abstract] [Full Text] [Related]
8. PTHrP-mediated hypercalcemia: causes and survival in 138 patients.
Donovan PJ; Achong N; Griffin K; Galligan J; Pretorius CJ; McLeod DS
J Clin Endocrinol Metab; 2015 May; 100(5):2024-9. PubMed ID: 25719931
[TBL] [Abstract][Full Text] [Related]
9. Denosumab is Effective for Controlling Serum Calcium Levels in Patients with Humoral Hypercalcemia of Malignancy Syndrome: A Case Report on Parathyroid Hormone-related Protein-producing Cholangiocarcinoma.
Ashihara N; Nakajima K; Nakamura Y; Kobayashi M; Shirahata K; Maeda C; Uehara T; Gomi D; Ito N
Intern Med; 2016; 55(23):3453-3457. PubMed ID: 27904108
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanism of action of parathyroid hormone related peptide in hypercalcemia of malignancy: therapeutic strategies (review).
Rabbani SA
Int J Oncol; 2000 Jan; 16(1):197-206. PubMed ID: 10601566
[TBL] [Abstract][Full Text] [Related]
11. Passive immunization with anti-parathyroid hormone-related protein monoclonal antibody markedly prolongs survival time of hypercalcemic nude mice bearing transplanted human PTHrP-producing tumors.
Sato K; Yamakawa Y; Shizume K; Satoh T; Nohtomi K; Demura H; Akatsu T; Nagata N; Kasahara T; Ohkawa H
J Bone Miner Res; 1993 Jul; 8(7):849-60. PubMed ID: 8352067
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy.
Schilling T; Pecherstorfer M; Blind E; Leidig G; Ziegler R; Raue F
J Clin Endocrinol Metab; 1993 Mar; 76(3):801-3. PubMed ID: 8445039
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone-related protein in tumor tissues obtained from patients with humoral hypercalcemia of malignancy.
Tsuchihashi T; Yamaguchi K; Miyake Y; Otsubo K; Nagasaki K; Honda S; Akiyama Y; Maeda Y; Koike M; Alper O
J Natl Cancer Inst; 1990 Jan; 82(1):40-4. PubMed ID: 2293655
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone related protein (PTHrP)-mediated hypercalcemia in malignancy associated with anti-PD-1 immune checkpoint inhibitor treatment and related inflammatory reactions.
Deligiorgi MV; Panayiotidis MI; Trafalis DT
Int Immunopharmacol; 2019 Dec; 77():105942. PubMed ID: 31699669
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone-related protein expression in human gastric adenocarcinomas not associated with hypercalcemia.
Abdeen O; Pandol SJ; Burton DW; Deftos LJ
Am J Gastroenterol; 1995 Oct; 90(10):1864-7. PubMed ID: 7572910
[TBL] [Abstract][Full Text] [Related]
16. Hypercalcemia of Malignancy Attributed to Cosecretion of PTH and PTHRP in Lung Adenocarcinoma.
Kroopnick JM; Martinez-Outschoorn U; Tuluc M; Kim CS
AACE Clin Case Rep; 2021; 7(3):200-203. PubMed ID: 34095488
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
[TBL] [Abstract][Full Text] [Related]
18. Levels of parathyroid hormone-related protein (PTHrP) in hypercalcemia of malignancy are not lowered by treatment with the bisphosphonate BM 21.0955.
Blind E; Raue F; Meinel T; Wüster C; Ziegler R
Horm Metab Res; 1993 Jan; 25(1):40-4. PubMed ID: 8428711
[TBL] [Abstract][Full Text] [Related]
19. Hypercalcemia of Malignancy: Simultaneous Elevation in Parathyroid Hormone-Related Peptide and 1,25 Dihydroxyvitamin D in Sarcoma.
Kim DW; Miller A; Li A; Hardy N; Silver KD
AACE Clin Case Rep; 2021; 7(3):169-173. PubMed ID: 34095480
[TBL] [Abstract][Full Text] [Related]
20. Fatal parathyroid hormone-related protein-induced humoral hypercalcemia of malignancy in a 3-month-old infant.
Lakhdir F; Lawson D; Schatz DA
Eur J Pediatr; 1994 Oct; 153(10):718-20. PubMed ID: 7813527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
